10Rx operates on a prepaid quarterly model: $299 every three months for compounded semaglutide, $450 for tirzepatide, with no membership fees. Here's how the cash-pay structure compares to month-to-month alternatives.

10Rx bundles clinician evaluation, next-day shipping, and support into its quarterly prepaid packages with no separate membership or per-visit fees. We break down what's included, the upfront quarterly cost, and how the effective monthly rate compares to month-to-month alternatives.

10Rx charges no separate membership fee; medication, consultation, shipping, and support are bundled into a quarterly prepaid package. We compare the all-in cost structure to month-to-month alternatives.

10Rx maintains the same quarterly package price across all available semaglutide and tirzepatide strengths. When your clinician increases your dose, your cost stays flat—but the prepaid quarterly commitment and per-month equivalent deserve a closer look.

10Rx offers only quarterly prepaid GLP-1 packages; PlexusDx provides month-to-month and multi-month options. We compare effective monthly costs, upfront commitments, and flexibility across both models.

10Rx charges a flat prepaid quarterly rate for compounded GLP-1 treatment—no first-month discount, no refill step-up. We calculate 12-month costs, compare like-for-like quarterly and month-to-month plans, and show what you pay over time.

10Rx charges $450 per quarter for compounded tirzepatide ($150/month prepaid), with no add-on fees and the same price at every dose—but requires upfront payment every three months and carries limited independent review evidence.

10Rx charges $299 for a three-month semaglutide package, paid upfront every quarter; no month-to-month option is documented. We break down the commitment, compare 12-month totals against flexible plans, and show what the prepaid structure means for your budget.

10Rx offers compounded GLP-1s at $299 quarterly for semaglutide and $450 for tirzepatide, with no add-on fees. We examine the pricing structure, pharmacy details, and the absence of independent review history.

Switching from 10Rx's quarterly prepaid model to PlexusDx's month-to-month pricing requires coordinating timing, prescriptions, and supply. Here's how to manage the transition without a dosing gap.

10Rx advertises $99.67/month semaglutide and $150/month tirzepatide as prepaid quarterly equivalents. We verified the pricing structure, examined the pharmacy disclosures, searched for independent reviews, and compared the quarterly prepay model to month-to-month alternatives.

BrightMeds and 10Rx both advertise quarterly GLP-1 packages below $100/month equivalent when paid upfront. We examine prepayment requirements, promotional limits, evidence quality, and total 12-month cost against PlexusDx's three-month commitment plans.

OatMeds offers 12-week prepaid packages starting at $297 for semaglutide and $399 for tirzepatide. 10Rx offers quarterly prepaid packages at $299 for semaglutide and $450 for tirzepatide.

AltRx offers 1-month and prepaid tiers for compounded tirzepatide; 10Rx sells only in quarterly packages. We normalize the economics, identify the hidden costs, and explain where PlexusDx fits.

10Rx charges $299 per quarter for semaglutide and $450 per quarter for tirzepatide, both prepaid in three-month packages. Here's what each plan includes and how the quarterly model compares to month-to-month alternatives.

10Rx charges $450 every three months for compounded tirzepatide injection—$150 per month when prepaid quarterly. We compare that upfront commitment model against month-to-month pricing and show the true 12-month cost.

10Rx's prepaid quarterly packages deliver the lowest per-month equivalent for compounded semaglutide and tirzepatide, but require upfront commitment. PlexusDx offers month-to-month flexibility and multi-month discounts. Here's what the structures cost over 12 months.